Allen DG Eccentric muscle damage: mechanisms of early reduction of force. Acta Physiol Scand. 2001 Mar;171(3):311-9. Review.
Balnave CD, Allen DG Intracellular calcium and force in single mouse muscle fibres following repeated contractions with stretch. J Physiol. 1995 Oct 1;488 ( Pt 1):25-36.
Balnave CD, Davey DF, Allen DG Distribution of sarcomere length and intracellular calcium in mouse skeletal muscle following stretch-induced injury. J Physiol. 1997 Aug 1;502 ( Pt 3):649-59.
Clarkson PM, Sayers SP Etiology of exercise-induced muscle damage. Can J Appl Physiol. 1999 Jun;24(3):234-48. Review.
Meyers BM, Cafarelli E Caffeine increases time to fatigue by maintaining force and not by altering firing rates during submaximal isometric contractions. J Appl Physiol (1985). 2005 Sep;99(3):1056-63. Epub 2005 May 5.
Nosaka K, Newton M Concentric or eccentric training effect on eccentric exercise-induced muscle damage. Med Sci Sports Exerc. 2002 Jan;34(1):63-9.
Ploutz-Snyder LL, Giamis EL, Formikell M, Rosenbaum AE Resistance training reduces susceptibility to eccentric exercise-induced muscle dysfunction in older women. J Gerontol A Biol Sci Med Sci. 2001 Sep;56(9):B384-90.
Warren GL, Ingalls CP, Lowe DA, Armstrong RB What mechanisms contribute to the strength loss that occurs during and in the recovery from skeletal muscle injury? J Orthop Sports Phys Ther. 2002 Feb;32(2):58-64. Review.
The Underlying Mechanisms From Exercise-induced Muscle Damage on Force Loss
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
